QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 301 filers reported holding QIAGEN NV in Q4 2021. The put-call ratio across all filers is 1.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $374,368 | +53.4% | 9,244 | +70.6% | 0.00% | – |
| Q2 2023 | $243,996 | +13.4% | 5,420 | +15.6% | 0.00% | – |
| Q1 2023 | $215,171 | -19.4% | 4,687 | -12.4% | 0.00% | -100.0% |
| Q4 2022 | $266,973 | +9.4% | 5,351 | -9.6% | 0.00% | 0.0% |
| Q3 2022 | $244,000 | -16.4% | 5,917 | -4.3% | 0.00% | 0.0% |
| Q2 2022 | $292,000 | -4.9% | 6,182 | +16.7% | 0.00% | 0.0% |
| Q1 2022 | $307,000 | -3.5% | 5,297 | -7.4% | 0.00% | 0.0% |
| Q4 2021 | $318,000 | +25.7% | 5,721 | +16.4% | 0.00% | 0.0% |
| Q3 2021 | $253,000 | -7.0% | 4,913 | -12.7% | 0.00% | 0.0% |
| Q2 2021 | $272,000 | -69.7% | 5,626 | -69.5% | 0.00% | -50.0% |
| Q1 2021 | $897,000 | +63.4% | 18,426 | +77.0% | 0.00% | +100.0% |
| Q4 2020 | $549,000 | +94.7% | 10,408 | +89.0% | 0.00% | 0.0% |
| Q3 2020 | $282,000 | -20.3% | 5,508 | -33.8% | 0.00% | 0.0% |
| Q2 2020 | $354,000 | -11.3% | 8,325 | -13.0% | 0.00% | -50.0% |
| Q1 2020 | $399,000 | – | 9,569 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SYCOMORE ASSET MANAGEMENT | 2,368,913 | $86,182,000 | 40.56% |
| Hardman Johnston Global Advisors LLC | 4,407,084 | $151,824,000 | 7.86% |
| Tikvah Management LLC | 442,942 | $15,259,000 | 5.41% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 2,594,057 | $88,155,000 | 3.09% |
| Opus Point Partners Management, LLC | 31,463 | $1,084,000 | 2.39% |
| SECTOR GAMMA AS | 407,406 | $14,035,000 | 2.36% |
| SANDLER CAPITAL MANAGEMENT | 804,049 | $27,699,000 | 2.35% |
| Sivik Global Healthcare LLC | 110,800 | $3,817,000 | 2.06% |
| Acorn Advisory Capital L.P. | 9,800 | $338,000 | 1.21% |
| Eversept Partners, LP | 55,300 | $1,905,085 | 1.03% |